RESULTS suggest that if a flowable hemostatic matrix ( rather than a non-flowable hemostat ) was utilized exclusively in 600 mixed cardiac surgeries annually , a hospital could improve patient outcomes by a reduction of 33 major complications , 76 minor complications , 54 surgical revisions , 194 transfusions , and 242 h of OR time .